Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salbutamol + theophylline is a combination medication primarily used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)[5][7]. This combination leverages the complementary mechanisms of both drugs to provide enhanced bronchodilation. ## Mechanism of Action The combination works through two distinct but synergistic pathways: 1. **Salbutamol** (also known as albuterol) is a selective beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle, providing quick relief from bronchospasm[3][10]. 2. **Theophylline** is a methylxanthine that causes bronchodilation by increasing cellular cyclic AMP through a different mechanism than salbutamol[4][6]. When combined, these medications appear to have a synergistic effect, potentially allowing for lower doses of each component while maintaining or enhancing therapeutic efficacy[4]. ## Clinical Use This combination is primarily prescribed for: - Management of asthma symptoms - Treatment of chronic obstructive pulmonary disease (COPD) - Relief of bronchospasm ## Dosage The appropriate dosage depends on the patient's age, gender, medical history, and specific formulation[7]. The medication is typically available in tablet form, often with salbutamol at 2mg and theophylline at 100mg per dose[4]. ## Side Effects Common side effects include: - Nausea and vomiting - Stomach pain - Headaches - Restlessness - Trembling or shaking - Difficulty sleeping - Increased heart rate (tachycardia)[1][5] ## Research Findings Research on this combination has shown mixed results: - Some studies indicate that the combination may produce negative interactions, including tachycardia and reduced therapeutic function when administered at maximum oral dosage[1]. - Other research suggests patients with chronic bronchitis may benefit from the combination if steady-state theophylline concentrations of 15-20 mg/l are achieved[2]. - A study with 36 perennial asthmatics found the combination to be superior to individual components due to synergistic effects, with no added side effects[4]. The combination should be used with caution, particularly in patients with certain medical conditions such as thyroid disorders, high blood pressure, heart disease, or diabetes[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Salbutamol + Theophylline.